KOCITAF

Kocitaf Tablets 30's

Name: Kocitaf Tablets 30's
Brand: KOCITAF
SKU: 08930
Price: 3750.00 KES
Availability: InStock

0.0 · 0 Ratings · 0 Reviews ·

KES 3,750

Price per Packets

In Stock

Standard Delivery: 4-6 hours

2 sold in the last 7 days

Overview

Kocitaf is a once-daily, single-tablet antiretroviral (ARV) medicine for HIV, combining three medicines. Dolutegravir, emtricitabine and tenofovir alafenamide. Together they lower the amount of HIV in the body, helping to protect the immune system, keep people well and reduce the risk of passing HIV to others when the virus is suppressed. Taken consistently, Kocitaf supports people living with HIV to stay healthy and live full lives.

Active ingredients: Dolutegravir (50mg) + Emtricitabine (200mg) + Tenofovir alafenamide (25mg). Confirm strengths on packaging.

Directions for Use

This is a prescription medicine started and monitored by an HIV clinician. Take one tablet once daily, with or without food, at about the same time each day. Taking it consistently every day keeps the medicine working and helps prevent resistance. Try to never miss a dose, and if you do, take it as soon as you remember unless it is almost time for the next one. Attend your routine clinic visits and blood tests.

This is a prescription medicine. Tell your doctor about all other medicines and supplements, as some (including certain antacids, mineral supplements and TB or seizure medicines) can interact. Separate antacids/iron/calcium from your dose as advised. Tell your doctor if you have kidney, liver, bone or hepatitis B concerns. Do not stop without medical advice. Use during pregnancy should be discussed with your clinician. If you have questions about HIV testing or treatment, speak confidentially with a healthcare provider or contact a local health clinic. This product information is for general guidance only and does not replace professional medical advice. Always consult a qualified healthcare provider before starting any new medication. Keep all medicines out of reach of children.